Leo Foundation's new CIO looks forward to life without MIFID II
At the start of October, a top member of Danske Capital's team swapped his job at the Danish banking group for the foundation that owns Danish drugmaker Leo Pharma. The limits of MIFID II are now a thing of the past, says Morten Stampe Christensen.
So far, there will be nine people at the office party this Christmas at Morten Stampe's new workplace, Leo Foundation, best known for owning the Danish drug company Leo Pharma A/S.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
